Vitamin D and the risk of dementia and Alzheimer disease

Objective: To determine whether low vitamin D concentrations are associated with an increased risk of incident all-cause dementia and Alzheimer disease. Methods: One thousand six hundred fifty-eight elderly ambulatory adults free from dementia, cardiovascular disease, and stroke who participated in the US population–based Cardiovascular Health Study between 1992–1993 and 1999 were included. Serum 25-hydroxyvitamin D (25(OH)D) concentrations were determined by liquid chromatography-tandem mass spectrometry from blood samples collected in 1992–1993. Incident all-cause dementia and Alzheimer disease status were assessed during follow-up using National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association criteria. Results: During a mean follow-up of 5.6 years, 171 participants developed all-cause dementia, including 102 cases of Alzheimer disease. Using Cox proportional hazards models, the multivariate adjusted hazard ratios (95% confidence interval [CI]) for incident all-cause dementia in participants who were severely 25(OH)D deficient (<25 nmol/L) and deficient (≥25 to <50 nmol/L) were 2.25 (95% CI: 1.23–4.13) and 1.53 (95% CI: 1.06–2.21) compared to participants with sufficient concentrations (≥50 nmol/L). The multivariate adjusted hazard ratios for incident Alzheimer disease in participants who were severely 25(OH)D deficient and deficient compared to participants with sufficient concentrations were 2.22 (95% CI: 1.02–4.83) and 1.69 (95% CI: 1.06–2.69). In multivariate adjusted penalized smoothing spline plots, the risk of all-cause dementia and Alzheimer disease markedly increased below a threshold of 50 nmol/L. Conclusion: Our results confirm that vitamin D deficiency is associated with a substantially increased risk of all-cause dementia and Alzheimer disease. This adds to the ongoing debate about the role of vitamin D in nonskeletal conditions.

[1]  L. Radloff The CES-D Scale , 1977 .

[2]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[3]  David A. Schoenfeld,et al.  Partial residuals for the proportional hazards regression model , 1982 .

[4]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[5]  Oscar L. Lopez,et al.  Evaluation of Dementia in the Cardiovascular Health Cognition Study , 2003, Neuroepidemiology.

[6]  Lewis H Kuller,et al.  Incidence and Prevalence of Dementia in the Cardiovascular Health Study , 2004, Journal of the American Geriatrics Society.

[7]  Steven A. Smith,et al.  Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. , 2005, Journal of chemical neuroanatomy.

[8]  J. McGrath,et al.  Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain , 2005, Journal of Chemical Neuroanatomy.

[9]  Karen W Phinney,et al.  Development of a standard reference material for vitamin D in serum. , 2008, The American journal of clinical nutrition.

[10]  I. Lang,et al.  Serum 25-Hydroxyvitamin D Concentration and Cognitive Impairment , 2009, Journal of geriatric psychiatry and neurology.

[11]  D. Eyles,et al.  Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases , 2009, Psychoneuroendocrinology.

[12]  K. Abel,et al.  1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. , 2009, Journal of Alzheimer's disease : JAD.

[13]  J. Brehm,et al.  Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. , 2010, The Journal of allergy and clinical immunology.

[14]  25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services , 2010, Neurology.

[15]  D. Le Gall,et al.  25-HYDROXYVITAMIN D, DEMENTIA, AND CEREBROVASCULAR PATHOLOGY IN ELDERS RECEIVING HOME SERVICES , 2010, Neurology.

[16]  D. Melzer,et al.  Vitamin D and risk of cognitive decline in elderly persons. , 2010, Archives of internal medicine.

[17]  J. Cauley,et al.  25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men , 2010, Neurology.

[18]  D. Melzer,et al.  Vitamin D and cognitive impairment in the elderly U.S. population. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[19]  Christine L. Taylor,et al.  Dietary Reference Intakes for Calcium and Vitamin D , 2016, Pediatric Clinical Practice Guidelines & Policies.

[20]  B. Kestenbaum,et al.  Vitamin D, parathyroid hormone, and cardiovascular events among older adults. , 2011, Journal of the American College of Cardiology.

[21]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[22]  C. Annweiler,et al.  Serum Vitamin D Deficiency as a Predictor of Incident Non-Alzheimer Dementias: A 7-Year Longitudinal Study , 2012, Dementia and Geriatric Cognitive Disorders.

[23]  I. Lang,et al.  Vitamin D, Cognitive Dysfunction and Dementia in Older Adults , 2011, CNS drugs.

[24]  S. Yılmazer,et al.  A novel perspective for Alzheimer's disease: vitamin D receptor suppression by amyloid-β and preventing the amyloid-β induced alterations by vitamin D in cortical neurons. , 2011, Journal of Alzheimer's disease : JAD.

[25]  H. Darwish,et al.  Vitamin D mitigates age-related cognitive decline through the modulation of pro-inflammatory state and decrease in amyloid burden , 2012, Journal of Neuroinflammation.

[26]  J. Manson,et al.  Calcium and Vitamin D Supplementation and Cognitive Impairment in the Women's Health Initiative , 2012, Journal of the American Geriatrics Society.

[27]  D. Viswanath,et al.  Dietary Reference Intakes for Calcium and Vitamin D , 2012, Pediatrics.

[28]  P. Griffin,et al.  Genomic and nongenomic signaling induced by 1α,25(OH)2-vitamin D3 promotes the recovery of amyloid-β phagocytosis by Alzheimer's disease macrophages. , 2012, Journal of Alzheimer's disease : JAD.

[29]  B. Kestenbaum,et al.  Serum 25-Hydroxyvitamin D Concentration and Risk for Major Clinical Disease Events in a Community-Based Population of Older Adults , 2012, Annals of Internal Medicine.

[30]  Cynthia Balion,et al.  Vitamin D, cognition, and dementia , 2012, Neurology.

[31]  J. Manson,et al.  Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies , 2012, Circulation. Cardiovascular quality and outcomes.

[32]  K. Yaffe,et al.  Association between serum 25(OH) vitamin D and the risk of cognitive decline in older women. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[33]  W. Thies,et al.  2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.

[34]  C. Annweiler,et al.  Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis. , 2013, Journal of Alzheimer's disease : JAD.

[35]  C. Annweiler,et al.  Vitamin D concentration and lateral cerebral ventricle volume in older adults. , 2013, Molecular nutrition & food research.

[36]  C. Annweiler,et al.  Meta-analysis of memory and executive dysfunctions in relation to vitamin D. , 2013, Journal of Alzheimer's disease : JAD.

[37]  S. Yılmazer,et al.  A new mechanism for amyloid-β induction of iNOS: vitamin D-VDR pathway disruption. , 2013, Journal of Alzheimer's disease : JAD.

[38]  B. Nordestgaard,et al.  25‐Hydroxyvitamin D and symptomatic ischemic stroke: An Original Study and Meta‐Analysis , 2013, Annals of neurology.

[39]  S. Bojesen,et al.  Reduced 25-hydroxyvitamin D and risk of Alzheimer’s disease and vascular dementia , 2014, Alzheimer's & Dementia.

[40]  S. Yılmazer,et al.  Why vitamin D in Alzheimer's disease? The hypothesis. , 2014, Journal of Alzheimer's disease : JAD.

[41]  P. Autier,et al.  Vitamin D status and ill health: a systematic review. , 2014, The lancet. Diabetes & endocrinology.